Tag: prospectus

Press release

HOUSTON, TX, June 24, 2025 (GLOBE NEWSWIRE) -- Houston American Energy Corp. (NYSE American: HUSA) (the “Company”) today announced that it has entered into a definitive agreement with an institutional investor (the “SPA”) for the purchase and sale of an aggregate of 81,629 shares of common stock at a purchase price of $14.80 per share in a registered direct offering (the “Offering”).

Terrestrial Energy’s Integral Molten Salt Reactor (IMSR) plant delivers uniquely adaptable output, enabling the customization and hybridization of its clean energy supply systems to meet specific customer requirements, including data centers and industrial heat applications

24 th June 2025

TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Lysander Funds Limited (“Lysander”) announced today management fee reductions, change in portfolio manager and change in risk ratings for certain of its mutual funds.  Details of these changes are set out below.

TORONTO, 23 juin 2025 (GLOBE NEWSWIRE) -- Lysander Funds Limited (« Lysander ») a annoncé aujourd’hui des réductions des frais de gestion, le remplacement d’un gestionnaire de portefeuille et la modification du niveau de risque de certains de ses organismes de placement collectif (OPC). Des détails sur ces changements sont donnés ci-après.

CALGARY, Alberta, June 23, 2025 (GLOBE NEWSWIRE) -- News Release – TC Energy Corporation (TSX:TRP) (NYSE:TRP) (TC Energy or the Company) today announced that 104,778 of its 9,997,177 fixed rate Cumulative Redeemable First Preferred Shares, Series 3 (Series 3 Shares) have been elected for conversion on June 30, 2025, on a one-for-one basis, into floating rate Cumulative Redeemable First Preferred Shares, Series 4 (Series 4 Shares); and 1,822,829 of its 4,002,823 Series 4 Shares have been elected for conversion, on a one-for-one basis, into Series 3 Shares.

Hong Kong, June 23, 2025 (GLOBE NEWSWIRE) -- Happy City Holdings Limited (Nasdaq: HCHL) (the “Company”), an established all-you-can-eat hotpot restaurant operator in Hong Kong , today announced the pricing of its initial public offering (the “Offering”) of 1,100,000 Class A ordinary shares (the “Class A Ordinary Shares”), at a price of $5.00 per Class A Ordinary Share (the “Offering Price”).

SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced its plans to commence an underwritten public offering, subject to market and other conditions, to issue and sell $250.0 million of shares of its common stock. All of the shares are being offered by Cidara. In connection with the proposed offering, Cidara expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering. There can be no assurance as to whether or when the proposed offering may be completed or as to the actual size or terms of the proposed offering.